Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RECOMBINANT-HUMAN-ERYTHROPOIETIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1732 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cooper, CA; Gasteiger, E; Packer, NH
      GlycoMod - A software tool for determining glycosylation compositions frommass spectrometric data

      PROTEOMICS
    2. Schett, G; Firbas, U; Fureder, W; Hiesberger, H; Winkler, S; Wachauer, D; Koller, M; Kapiotis, S; Smolen, J
      Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus

      RHEUMATOLOGY
    3. d'Onofrio, G; Mistretta, G; Giordano, G; Zini, G
      Erythropoietic function assessment: Development of methodology - the Sysmex XE-2100 (TM)

      INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    4. Kusano, E; Akimoto, T; Umino, T; Yanagiba, S; Inoue, M; Ito, C; Ando, Y; Asano, Y
      Modulation of endothelin-1-induced cytosolic free calcium mobilization andmitogen-activated protein kinase activation by erythropoietin in vascular smooth muscle cells

      KIDNEY & BLOOD PRESSURE RESEARCH
    5. Rodgers, GP; Saunthararajah, Y
      Advances in experimental treatment of beta-thalassaemia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    6. Joy, MS
      Novel erythropoiesis-stimulating protein - An erythropoietin analogue withan extended half-life and less frequent dosing

      FORMULARY
    7. Semba, RD; Gray, GE
      Pathogenesis of anemia during human immunodeficiency virus infection

      JOURNAL OF INVESTIGATIVE MEDICINE
    8. Pollak, VE; Lorch, JA; Means, RT
      Unanticipated favorable effects of correcting iron deficiency in chronic hemodialysis patients

      JOURNAL OF INVESTIGATIVE MEDICINE
    9. Magnani, M; Corsi, D; Bianchi, M; Paiardini, M; Galluzzi, L; Gargiullo, E; Parisi, A; Pigozzi, F
      Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes

      BLOOD CELLS MOLECULES AND DISEASES
    10. Chavers, B; Schnaper, HW
      Risk factors for cardiovascular disease in children on maintenance dialysis

      ADVANCES IN RENAL REPLACEMENT THERAPY
    11. Rosse, WF
      New insights into paroxysmal nocturnal hemoglobinuria

      CURRENT OPINION IN HEMATOLOGY
    12. Vaziri, ND
      Cardiovascular effects of erythropoietin and anemia correction

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    13. Armstrong, WS; Kazanjian, P
      Use of cytokines in human immunodeficiency virus-infected patients: Colony-stimulating factors, erythropoietin, and interleukin-2

      CLINICAL INFECTIOUS DISEASES
    14. Schumacher, YO; Schmid, A; Lenz, T; Keul, J
      Blood testing in sports: Hematological profile of a convicted athlete

      CLINICAL JOURNAL OF SPORT MEDICINE
    15. Tamussino, KF; Gucer, F; Reich, O; Moser, F; Petru, E; Scholz, HS
      Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    16. Middleton, RJ; Parfrey, PS; Foley, RN
      Left ventricular hypertrophy in the renal patient

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    17. London, GM; Pannier, B; Guerin, AP; Blacher, J; Marchais, SJ; Darne, B; Metivier, F; Adda, H; Safar, ME
      Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    18. Bartholomew, A; Patil, S; Mackay, A; Nelson, M; Buyaner, D; Hardy, W; Mosca, J; Sturgeon, C; Siatskas, M; Mahmud, N; Ferrer, K; Deans, R; Moseley, A; Hoffman, R; Devine, SM
      Baboon mesenchymal stem cells can be genetically modified to secrete humanerythropoietin in vivo

      HUMAN GENE THERAPY
    19. Christopoulou, M; Derartinian, H; Hatzidimitriou, G; Iatrou, I
      Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin

      JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
    20. Maruyama, H; Ataka, K; Gejyo, F; Higuchi, N; Ito, Y; Hirahara, H; Imazeki, I; Hirata, M; Ichikawa, F; Neichi, T; Kikuchi, H; Sugawa, M; Miyazaki, J
      Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats

      GENE THERAPY
    21. Shapira, Y; Bairey, O; Vatury, M; Magen-Nativ, H; Prokocimer, M; Sagie, A
      Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia: Case reports and literature review

      JOURNAL OF HEART VALVE DISEASE
    22. Tappe, K; Turkelson, C; Doggett, D; Coates, V
      Disability under Social Security for patients with ESRD: an evidence-basedreview

      DISABILITY AND REHABILITATION
    23. Libretto, SE; Barrett-Lee, PJ; Gorst, DW; Kaczmarski, R; McAdam, K; Stevenson, P; Thomas, R
      Improvement in quality of life for cancer patients treated with epoetin alfa

      EUROPEAN JOURNAL OF CANCER CARE
    24. Coiffier, B; Guastalla, JP; Pujade-Lauraine, E; Bastit, P
      Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey

      EUROPEAN JOURNAL OF CANCER
    25. Jelkmann, W
      The role of the liver in the production of thrombopoietin compared with erythropoietin

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    26. Abdelfatah, AB; Motte, G; Ducloux, D; Chalopin, JM
      Determinants of mean arterial pressure and pulse pressure in chronic haemodialysis patients

      JOURNAL OF HUMAN HYPERTENSION
    27. Lezaic, V; Biljanovic-Paunovic, L; Pavlovic-Kentera, V; Djukanovic, L
      Erythropoiesis after kidney transplantation: The role of erythropoietin, burst promoting activity and early erythroid progenitor cells

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    28. Makis, AC; Chaliasos, N; Hatzimichael, EC; Bourantas, KL
      Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient

      ANNALS OF HEMATOLOGY
    29. Yang, MH; Hsu, HC
      Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review

      ANNALS OF HEMATOLOGY
    30. Aksoy, MC; Tokgozoglu, AM
      Erythropoietin for autologous blood donation in fetal hip arthroplasty patients

      ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
    31. Kato, A; Odamaki, M; Takita, T; Furuhashi, M; Maruyama, Y; Hishida, A
      High blood soluble receptor p80 for tumour necrosis factor-alpha is associated with erythropoietin resistance in haemodialysis patients

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    32. Schiffl, H; Lang, SM; Stratakis, D; Fischer, R
      Effects of ultrapure dialysis fluid on nutritional status and inflammatoryparameters

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    33. Johnson, DW; Herzig, KA; Gissane, R; Campbell, SB; Hawley, CM; Isbel, NM
      A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    34. Karpati, I; Seres, I; Matyus, J; Ben, T; Paragh, G; Varga, Z; Kakuk, G
      Which parameters affect cytosolic free calcium in polymorphonuclear leukocytes of haemodialysis patients?

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    35. Kosch, M; Bahner, U; Bettger, H; Matzkies, F; Teschner, M; Schaefer, RM
      A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer (R)) vs iron gluconate (Ferrlecit (R)) in haemodialysispatients treated with rHuEpo

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    36. Bagnis, C; Beaufils, H; Jacquiaud, C; Adabra, Y; Jouanneau, C; Le Nahour, G; Jaudon, MC; Bourbouze, R; Jacobs, C; Deray, G
      Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    37. Stoves, J; Inglis, H; Newstead, CG
      A randomized study of oral vs intravenous iron supplementation in patientswith progressive renal insufficiency treated with erythropoietin

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    38. Schunkert, H; Hense, HW
      A heart price to pay for anaemia

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    39. Akimoto, T; Kusano, E; Fujita, N; Okada, K; Saito, O; Ono, S; Ando, Y; Homma, S; Saito, T; Asano, Y
      Erythropoietin modulates angiotensin II- or noradrenaline-induced Ca2+ mobilization in cultured rat vascular smooth-muscle cells

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    40. Itri, LM
      Cancer-related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapy

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    41. Weiss, LG
      Is the use of subcutaneous epoetin beta once a week really equivalent to amore frequent administration of the same total dose? Reply

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    42. Goicoechea, M; Caramelo, C; Rodriguez, P; Verde, E; Gruss, E; Albalate, M; Ortiz, A; Casado, S; Valderrabano, F
      Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    43. Locatelli, F; Del Vecchio, L; Andrulli, S
      The modality of dialysis treatment: does it influence the response to erythropoietin treatment?

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    44. Eckardt, KU
      Anaemia in end-stage renal disease: pathophysiological considerations

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    45. Macdougall, IC
      Individualizing target haemoglobin concentrations - tailoring treatment for renal anaemia

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    46. Stenvinkel, P
      The role of inflammation in the anaemia of end-stage renal disease

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    47. Ritz, E
      Advances in nephrology: successes and lessons learnt from diabetes mellitus

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    48. Tarng, DC; Huang, TP; Wei, YH
      Erythropoietin and iron: the role of ascorbic acid

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    49. Eknoyan, G
      The importance of early treatment of the anaemia of chronic kidney disease

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    50. Macdougall, IC
      Present and future strategies in the treatment of renal anaemia

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    51. Egrie, JC; Browne, JK
      Development and characterization of novel erythropoiesis stimulating protein (NESP)

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    52. Macdougall, IC
      An overview of the efficacy and safety of novel erythropoiesis stimulatingprotein (NESP)

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    53. Aljama, P; Bommer, J; Canaud, B; Carrera, F; Eckardt, KU; Horl, WH; Kredict, RT; Locatelli, F; Macdougall, IC; Wikstrom, B
      Practical guidelines for the use of NESP in treating renal anaemia

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    54. Valderrabano, F
      Building a healthier heart through early anaemia correction - Proceedings of a Technical Forum held at the 37th ERA-EDTA Congress - 19 September 2000- Nice, France - Introduction

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    55. Portoles, J
      The beneficial effects of intervention in early renal disease

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    56. Eckardt, KU
      The CREATE trial - building the evidence

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    57. Morgan, HEG; Gautam, M; Geary, DF
      Maintenance intravenous iron therapy in pediatric hemodialysis patients

      PEDIATRIC NEPHROLOGY
    58. Hays, S; Guy, B; Boulard, MS; Bourgeois, J; Blondet, C; Putet, G
      Blood transfusion despite early use of erythropoietin: prospective study of an annual cohort of premature infants weighing less than 1,500 g

      ARCHIVES DE PEDIATRIE
    59. Kuriyama, S; Tomonari, H; Tokudome, G; Kaguchi, Y; Hayashi, H; Kobayashi, H; Horiguchi, M; Ishikawa, M; Hara, Y; Hosoya, T
      Association of angiotensinogen gene polymorphism with erythropoietin-induced hypertension: a preliminary report

      Hypertension research
    60. Izumi, M; Takeshita, A; Shinjo, K; Naito, K; Matsui, H; Shibata, K; Ohnishi, K; Kanno, T; Ohno, R
      Decreased amount of mpl and reduced expression of glycoprotein IIb/IIIa and glycoprotein Ib on platelets from patients with refractory anemia: analysis by a non-isotopic quantitative ligand binding assay and immunofluorescence

      EUROPEAN JOURNAL OF HAEMATOLOGY
    61. Voulgari, PV; Hatzimichael, EC; Tsiara, S; Tzallas, C; Drosos, AA; Bourantas, KL
      Investigation for the presence of antierythropoietin antibodies in patients with myelodysplastic syndromes

      EUROPEAN JOURNAL OF HAEMATOLOGY
    62. Muller, HM; Horina, JH; Kniepeiss, D; Tripolt, MB; Stadelbauer, V; Schweiger, M; Tscheliessnigg, KH
      Characteristics and clinical relevance of chronic anemia in adult heart transplant recipients

      CLINICAL TRANSPLANTATION
    63. Oettle, H; Riess, H; Raguse, JD; Bier, J; Gath, HJ
      Recombinant human erythropoietin in the treatment of head and neck tumour anaemia

      INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
    64. Tokgoz, B; Utas, C; Dogukan, A; Guven, M; Taskapan, H; Oymak, O; Kelestimur, F
      Effects of long-term erythropoietin therapy on the hypothalamopituitary-testicular axis in male CAPD patients

      PERITONEAL DIALYSIS INTERNATIONAL
    65. Prakash, S; Walele, A; Dimkovic, N; Bargman, J; Vas, S; Oreopoulos, D
      Experience with a large dose (500 mg) of intravenous iron dextran and ironsaccharate in peritoneal dialysis patients

      PERITONEAL DIALYSIS INTERNATIONAL
    66. Rusthoven, E; van de Kar, NCAJ; Monnens, LAH; Schroder, CH
      Long-term effectiveness of intraperitoneal erythropoietin in children on NIPD by administration in small bags

      PERITONEAL DIALYSIS INTERNATIONAL
    67. Navarro, JF; Mora, C
      Effect of androgens on anemia and malnutrition in renal failure: Implications for patients on peritoneal dialysis

      PERITONEAL DIALYSIS INTERNATIONAL
    68. Schroder, CH; Swinkels, LMJW; Reddingius, RE; Sweep, FGJ; Willems, HL; Monnens, LAH
      Adsorption of erythropoietin and growth hormone to peritoneal dialysis bags and tubing

      PERITONEAL DIALYSIS INTERNATIONAL
    69. Diamond, PT; Julian, DM
      Practice trends in the management of low hematocrit in the acute rehabilitation setting

      AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
    70. Ahmad, S
      L-carnitine in dialysis patients

      SEMINARS IN DIALYSIS
    71. Hamada, S; Sutou, S; Morita, T; Wakata, A; Asanami, S; Hosoya, S; Ozawa, S; Kondo, K; Nakajima, M; Shimada, H; Osawa, K; Kondo, Y; Asano, N; Sato, S; Tamura, H; Yajima, N; Marshall, R; Moore, C; Blakey, DH; Schechtman, LM; Weaver, JL; Torous, DK; Proudlock, R; Ito, S; Namiki, C; Hayashi, M
      Evaluation of the rodent micronucleus assay by a 28-day treatment protocol: Summary of the 13th Collaborative Study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Environmental Mutagen Society of Japan (JEMS)-Mammalian Mutagenicity Study Group (MMS)

      ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
    72. Ifudu, O
      Maximizing response to erythropoietin in treating HIV-associated anemia

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    73. Riley, RS; Ben-Ezra, JM; Goel, R; Tidwell, A
      Reticulocytes and reticulocyte enumeration

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    74. Turner, R; Anglin, P; Burkes, R; Couture, F; Evans, W; Goss, G; Grimshaw, R; Melosky, B; Paterson, A; Quirt, I
      Epoetin alfa in cancer patients: Evidence-based guidelines

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    75. Rodriquez, RM; Corwin, HL; Gettinger, A; Corwin, MJ; Gubler, D; Pearl, RG
      Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness

      JOURNAL OF CRITICAL CARE
    76. Hardy, JF
      Pharmacological strategies for blood conservation in cardiac surgery: erythropoietin and antifibrinolytics

      CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE
    77. Silverberg, DS; Wexler, D; Sheps, D; Blum, M; Keren, G; Baruch, R; Schwartz, D; Yachnin, T; Steinbruch, S; Shapira, I; Laniado, S; Iaina, A
      The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    78. Quirt, I; Robeson, C; Lau, CY; Kovacs, M; Burdette-Radoux, S; Dolan, S; Tang, SC; McKenzie, M; Couture, F
      Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy

      JOURNAL OF CLINICAL ONCOLOGY
    79. Kurzrock, R; Cortes, J; Thomas, DA; Jeha, S; Pilat, S; Talpaz, M
      Pilot study of low-dose interleukin-11 in patients with bone marrow failure

      JOURNAL OF CLINICAL ONCOLOGY
    80. Littlewood, TJ; Bajetta, E; Nortier, JWR; Vercammen, E; Rapoport, B
      Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized,double-blind, placebo-controlled trial

      JOURNAL OF CLINICAL ONCOLOGY
    81. Gabrilove, JL; Cleeland, CS; Livingston, RB; Sarokhan, B; Winer, E; Einhorn, LH
      Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing

      JOURNAL OF CLINICAL ONCOLOGY
    82. Dempke, W; Schmoll, HJ
      Possible new indications for the treatment with erythropoietin

      MEDIZINISCHE KLINIK
    83. Johansen, KL
      The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    84. Alessandrino, EP; Amadori, S; Cazzola, M; Locatelli, F; Mecucci, C; Morra, E; Saglio, G; Visani, G; Tura, S
      Myelodysplastic syndromes: recent advances

      HAEMATOLOGICA
    85. Sautois, B; Baudoux, E; Salmon, JP; Michaux, S; Schaaf-Lafontaine, N; Pereira, M; Paulus, JM; Fillet, G; Beguin, Y
      Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation

      HAEMATOLOGICA
    86. Musto, P; Sanpaolo, G; D'Arena, G; Scalzulli, PR; Matera, R; Falcone, A; Bodenizza, C; Perla, G; Carotenuto, M
      Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone

      HAEMATOLOGICA
    87. Sifakis, S; Angelakis, E; Vardaki, E; Koumantaki, Y; Matalliotakis, I; Koumantakis, E
      Erythropoietin in the treatment of iron deficiency anemia during pregnancy

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    88. Henke, M
      Correction of cancer anemia - Impact on disease course, prognosis and treatment efficacy, particularly for patients undergoing radiotherapy

      ONKOLOGIE
    89. Kavanagh, BD; Fischer, BA; Segreti, EM; Wheelock, JB; Boardman, C; Roseff, SD; Cardinale, RM; Benedict, SH; Goram, AL
      Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    90. Earnshaw, P
      Blood conservation in orthopaedic surgery: the role of epoetin alfa

      INTERNATIONAL ORTHOPAEDICS
    91. Albers, P; Heicappell, R; Schwaibold, H; Wolff, JM
      Erythropoetin in urologic oncology

      EUROPEAN UROLOGY
    92. Chapel, SH; Veng-Pedersen, P; Schmidt, RL; Widness, JA
      Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics

      EXPERIMENTAL HEMATOLOGY
    93. Payen, E; Bettan, M; Rouyer-Fessard, P; Beuzard, Y; Scherman, D
      Improvement of mouse beta-thalassemia by electrotransfer of erythropoietincDNA

      EXPERIMENTAL HEMATOLOGY
    94. Coccia, MA; Cooke, K; Stoney, G; Pistillo, J; Del Castillo, J; Duryea, D; Tarpley, JE; Molineux, G
      Novel erythropoiesis stimulating protein (darbepoetin alfa) alleviates anemia associated with chronic inflammatory disease in a rodent model

      EXPERIMENTAL HEMATOLOGY
    95. Pedain, C; Herrero, J; Kunzel, W
      Serum erythropoietin levels in ovarian cancer patients receiving chemotherapy

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    96. Lacson, E; Diaz-Buxo, JA
      The treatment of anemia in peritoneal dialysis patients

      CLINICAL NEPHROLOGY
    97. Utas, C; Taskapan, H; Oymak, O; Akpolat, T; Arinsoy, T; Kelestimur, F
      Improvement of thyroid hormone profile and thyrotrophin (TSH) surge alterations in hemodialysis patients on erythropoietin treatment

      CLINICAL NEPHROLOGY
    98. Silverberg, DS; Blum, M; Agbaria, Z; Deutsch, V; Irony, M; Schwartz, D; Baruch, R; Yachnin, T; Steinbruch, S; Iaina, A
      The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period

      CLINICAL NEPHROLOGY
    99. Varki, A
      N-glycolylneuraminic acid deficiency in humans

      BIOCHIMIE
    100. Cantoni, S; Morra, E
      Anemia of cancer: An overview

      TUMORI


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 19:22:24